Riskpilot← Back to searchSign inGet full accessDisruptive Pharma Holding AB (publ)
ABActiveOrg 5593106361UppsalaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
SEK 0
EBITDA margin
—
-1% vs 2023
Equity ratio
99.6%
Financial strength
Net profit 2024
SEK -29,9M
-24% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,1M | -1% |
| Net profit | SEK -29,9M | -24% |
| Total assets | SEK 17,6M | -21% |
| Equity | SEK 17,5M | -21% |
| Employees | 0 | — |
Legal name
Disruptive Pharma Holding AB (publ)
Org number
5593106361
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7 april 2021
Share capital
SEK 3 724 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med en av externa firmatecknaren Åsberg, Dan Peter Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, direkt eller indirekt, bedriva forsknings- utvecklings-, försäljnings- och licensieringsverksamhet inom kemi-, läkemedels- och livsmedelsområdet samt därmed förenlig verksamhet.
Address
Uppsala
Email
stefan.strom@disruptivepharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 69 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −179 | −379 | −1 080 | −1 088 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −179 | −379 | −1 080 | −1 088 |
| Net financials | −21 000 | −20 969 | −22 946 | −28 774 |
| Profit before tax | −10 679 | −21 348 | −24 025 | −29 862 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −10 679 | −21 348 | −24 025 | −29 862 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 27 355 | 46 366 | 22 364 | 17 600 |
| Equity | 27 216 | 46 307 | 22 314 | 17 525 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 139 | 59 | 50 | 75 |
| Total debt | 139 | 59 | 50 | 75 |
EBITDA margin
-108800000.0%
This company
15.8%
Market median
-688607695% vs market
20212024
Equity ratio
99.6%
This company
38.2%
Market median
+161% vs market
20212024
Return on equity
-170.4%
This company
18.4%
Market median
-1026% vs market
20212024
Net profit margin
-2986200000.0%
This company
8.1%
Market median
-36866666767% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
DP Chief Executive Officer | Chief Executive Officer | 2021 |
PS External Signatory | External Signatory | 2022 |
JE Chief Auditor | Chief Auditor | 2021 |
| Former (3) | ||
OH Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
EM External Signatory | External Signatory | 2021 – 2022 |
KL Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2026 | |
| Board of Directors | 2022 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Chairman | 2021 – 2026 | |
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Disruptive Pharma Holding AB (publ) 
Disruptive Pharma ABBoard members of Disruptive Pharma Holding AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Peter Åsberg | Chief Executive Officer | 0 companies |
| Per Stefan Ström | External Signatory | 0 companies |
| Oskar Henrik Gauther Lund | Chief Executive Officer | 0 companies |
| Eva Maria Andersson Dverstorp | External Signatory | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Ylva Gunilla Ekström | Chairman | 0 companies |
| Björn Christian Alexander Oker-Blom | Board of Directors | 0 companies |
| David Olof Rikard Bejker | Board of Directors | 0 companies |
| Marie Elisabeth Ehrling | Chairman | 0 companies |
| Maria Strömme | Board of Directors | 0 companies |
| Jacob Uno Stanley Gunterberg | Board of Directors | 0 companies |